Contineum Therapeutics CTNM
NASDAQ CTNM
$12.99 -0.43 (-3.20%)
At close: Oct 1, 2026 · 4:00 PM EDT

Contineum Therapeutics (CTNM) Accumulated Depreciation (2023 - 2024)

Updated

Contineum Therapeutics (CTNM) recorded Accumulated Depreciation of $1.72 million in Q4 2024, up 16.2% from $1.48 million a year earlier.

Analysis

Contineum Therapeutics (CTNM) Accumulated Depreciation (2023 - 2024) Analysis & Trends

  • Across earlier years, Accumulated Depreciation came in at $1.48 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Contineum Therapeutics 502.82 Mn 502.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.72 Mn
Dec 31, 2023 1.48 Mn
API Access

Contineum Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=CTNM&period=max&api_key=YOUR_API_KEY